비아트리스 (VTRS)

Nov 11, 2025

Viatris Inc. stock rises Tuesday, outperforms market - MSN

Nov 11, 2025

Nov 11, 2025

Evaluating Viatris (VTRS) Valuation After Strong Q3 Results and Upbeat 2025 Guidance - simplywall.st

Nov 11, 2025

Nov 11, 2025

What drives Viatris Inc VIA stock priceChart Pattern Recognition & Small Budget Investment Tips - earlytimes.in

Nov 11, 2025

Nov 11, 2025

U.S. Markets Finished Mixed Tuesday As Viatris Led, CoreWeave Lagged - Barron's

Nov 11, 2025

Nov 11, 2025

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know - Yahoo Finance

Nov 11, 2025

Nov 11, 2025

What technical charts say about Viatris Inc. stock2025 AllTime Highs & Safe Capital Growth Trade Ideas - newser.com

Nov 11, 2025

Nov 11, 2025

Viatris at UBS Global Healthcare Conference: Strategic Growth Initiatives - Investing.com India

Nov 11, 2025

Nov 11, 2025

Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J&J, Sun Pharma, Lupin Pharma, GlaxoSmithKline, Bayer, United Therapeutics - Yahoo Finance

Nov 11, 2025

Nov 11, 2025

Will Viatris Inc. (VIA) stock benefit from commodity supercycleJuly 2025 Review & Risk Controlled Stock Alerts - newser.com

Nov 11, 2025

Nov 11, 2025

Is now a turning point for Viatris Inc.Trade Volume Summary & Consistent Profit Alerts - newser.com

Nov 11, 2025

Nov 11, 2025

Is it time to cut losses on Viatris Inc.Weekly Risk Report & Reliable Intraday Trade Alerts - newser.com

Nov 11, 2025

Nov 11, 2025

Will Viatris Inc. stock return to pre crisis levelsJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com

Nov 11, 2025

Nov 11, 2025

What is the fair value estimate for Viatris Inc. (VIA) stock in 2025Rate Cut & Free High Return Stock Watch Alerts - newser.com

Nov 11, 2025

Nov 10, 2025

Can Viatris Inc. (VIA) stock surprise markets with earningsCEO Change & Weekly Watchlist for Hot Stocks - newser.com

Nov 10, 2025

Nov 10, 2025

Type 2 Diabetes MarketSee Which Drugs Are Leading in 2025Novo - openPR.com

Nov 10, 2025

Nov 10, 2025

Viatris’ Indore Plant Remediation ‘Largely Complete’ As FDA Re-Inspection Looms - Citeline News & Insights

Nov 10, 2025

Nov 10, 2025

Is Viatris Inc. stock a good choice for value investors2025 Major Catalysts & Accurate Technical Buy Alerts - newser.com

Nov 10, 2025

Nov 10, 2025

Will Viatris Inc. stock recover faster than peers2025 Key Lessons & Capital Efficiency Focused Strategies - newser.com

Nov 10, 2025

Nov 10, 2025

Using AI based signals to follow Viatris Inc.Weekly Gains Summary & Breakout Confirmation Trade Signals - newser.com

Nov 10, 2025

Nov 10, 2025

Viatris Inc. stock outlook for YEARPortfolio Risk Summary & Weekly Breakout Watchlists - newser.com

Nov 10, 2025

Nov 09, 2025

How (VTRS) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Nov 09, 2025

Nov 09, 2025

What does recent volatility data suggest for Viatris Inc.Earnings Beat & Target Return Focused Stock Picks - newser.com

Nov 09, 2025

Nov 08, 2025

How Upgraded Guidance and Capital Returns at Viatris (VTRS) Have Changed Its Investment Story - Yahoo Finance

Nov 08, 2025

Nov 08, 2025

Why Viatris Inc. stock could be next big winnerWeekly Market Report & Technical Pattern Based Signals - newser.com

Nov 08, 2025

Nov 07, 2025

Viatris Inc. (NASDAQ:VTRS) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 07, 2025

Nov 07, 2025

Viatris Nears Completion Of Company-Wide Strategic Review - Citeline News & Insights

Nov 07, 2025

Nov 07, 2025

Viatris: Q3 Earnings Snapshot - ctinsider.com

Nov 07, 2025

Nov 07, 2025

Viatris Q3 2025 presentation slides: Raises full-year guidance despite GAAP losses - Investing.com Nigeria

Nov 07, 2025

Nov 07, 2025

Viatris Lifts Forecasts After Branded Drug Sales Outpace Estimates - Finimize

Nov 07, 2025

Nov 07, 2025

Viatris Inc. Reports Steady Q3 2025 Performance - TipRanks

Nov 07, 2025

Nov 06, 2025

Viatris, Inc. Earnings Call: Mixed Sentiment and Strategic Focus - TipRanks

Nov 06, 2025

Nov 06, 2025

3rd Circ. Won't Revive Investors' Suit Over Viatris Sale - Law360

Nov 06, 2025

Nov 06, 2025

Viatris (VTRS) Q3 2025 Earnings Call Transcript - Fortune

Nov 06, 2025

Nov 06, 2025

Viatris Inc (VTRS) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing Growth ... By GuruFocus - Investing.com Canada

Nov 06, 2025

Nov 06, 2025

Can volume confirm reversal in Viatris Inc.Trade Analysis Report & Expert Approved Momentum Ideas - newser.com

Nov 06, 2025

Nov 06, 2025

Viatris Outpaces Expectations And Lifts Guidance After New Deal - Finimize

Nov 06, 2025

Nov 06, 2025

Viagra-maker Viatris beats quarterly estimates on strong demand for branded drugs - MSN

Nov 06, 2025

Nov 06, 2025

Viatris Q3 2025 presentation slides: Raises full-year guidance despite GAAP losses By Investing.com - Investing.com South Africa

Nov 06, 2025

Nov 06, 2025

Earnings call transcript: Viatris Q3 2025 beats earnings expectations, stock dips - Investing.com India

Nov 06, 2025

Nov 06, 2025

Needle-Free Devices, Technologies and Global Markets - GlobeNewswire

Nov 06, 2025

Nov 06, 2025

Needle-Free Devices, Technologies and Global Markets (2025-2030) Featuring Profiles of GSK, Novartis, Viatris, PharmaJet and Other Key Players - Yahoo Finance

Nov 06, 2025

Nov 06, 2025

Viatris Investors Lose Bid to Revive Biosimilars Spinoff Suit - Bloomberg Law News

Nov 06, 2025

Nov 06, 2025

Viatris Shows Improved Relative Strength; Still Shy Of Benchmark - MSN

Nov 06, 2025

Nov 06, 2025

Viatris Tops Q3 Earnings & Revenue Estimates, Ups '25 Guidance - Nasdaq

Nov 06, 2025

Nov 06, 2025

Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance - AlphaStreet

Nov 06, 2025